Pharmacological Strategies for Providing Patients With Delirium Relief From Terminal Dyspnea: A Secondary Data Analysis
The combined distressing symptoms of dyspnea and delirium during the last days of life are likely to be refractory suffering, which shows a poor response to pharmacological interventions, including opioids and antipsychotics.
Authors
- Takaaki Hasegawa (ORCID: https://orcid.org/0000-0001-7894-4528)
- Yutaka Hatano (ORCID: https://orcid.org/0000-0002-9797-3487)
- Isseki Maeda (ORCID: https://orcid.org/0000-0002-0018-3359)
- Yoshinobu Matsuda (ORCID: https://orcid.org/0000-0001-5092-9377)
- Tatsuya Morita (ORCID: https://orcid.org/0000-0002-7257-7429)
- Jun Hamano (ORCID: https://orcid.org/0000-0003-0304-9881)
- Naosuke Yokomichi (ORCID: https://orcid.org/0000-0003-0863-1184)
- Takashi Yamaguchi (ORCID: https://orcid.org/0000-0003-3060-0245)
- Masanori Mori (ORCID: https://orcid.org/0000-0002-5489-9395)
- Kengo Imai (ORCID: https://orcid.org/0009-0003-6962-1518)
Institutions
- University of Tsukuba (JP)
- Seirei Mikatabara General Hospital (JP)
- Hiroshima Kyoritsu Hospital (JP)
- Nagoya City University Hospital (JP)
- NHO Kinki Chuo Chest Medical Center (JP)
- Kobe University (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/cam4.70677
- Citations
- 1
- Primary Topic
- Intensive Care Unit Cognitive Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- Aichi Cancer Research Foundation
- Japan Society for the Promotion of Science